glp-1/gip agonists Schematic illustration of monoagonists, dual and triple LY3437943, a novel triple glucagon,
Description
Discovery of gastric inhibitory polypeptide and its subsequent fate: personal reflections
Analysis of the LEADER trial data demonstrated that liraglutide exerted a 22% decline in the morbidity of newly diagnosed or aggravated nephropathy [4]
2023;14 doi: 10.3389/FENDO.2023.1085799
Srivastava, G
